The present invention relates to compounds represented by formula (I) or composition comprising at least one of such compounds, which are inhibitors of histone deacetylase. The detailed description of these compounds is disclosed in the Description. These compounds and the composition comprising the same may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase (HDAC) activities.
本发明涉及
化学式(I)所代表的化合物或含有这些化合物中至少一种的组合物,这些化合物是组蛋白
去乙酰化酶的
抑制剂。这些化合物的详细描述在说明书中公开。这些化合物和含有它们的组合物可能作为药物用于治疗增生性疾病以及涉及、与或相关的组蛋白
去乙酰化酶(H
DAC)活性的其他疾病。